Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

A Novel Method of Stromal Analysis Based on Polarized Light Microscopy is Prognostic of Breast Cancer Progression and Outcomes

FY 2019-20

Summary
"Breast cancer is one of the most commonly diagnosed cancers and is the leading cause of cancer death among women worldwide. It is a highly heterogenous disease with much variation among patients in terms of disease progression and aggressiveness. Despite this known heterogeneity, personalized therapy based on prognostic markers remains difficult to implement, often leading to over- or under-treatment. The morphologic features of the tumour-associated stroma have recently been shown to contain prognostic information. In response, our group has developed a simple and inexpensive method to evaluate stromal morphology based on polarized light microscopy. By exploiting the birefringent properties of collagen (a major component of the stroma) and its interaction with polarized light, it is possible to visualize the stroma to glean prognostic information. We have also developed a ""stromal architecture signature"" (SAS), a numerical score that quantifies the patterns of stromal morphology. This research will further develop this novel methodology and will examine how the SAS is prognostic of breast cancer progression and outcomes. It will also produce a clinical workflow to facilitate uptake of this method and use of its prognostic data as a step toward making personalized therapy more readily available. An approach that is inexpensive, reliable, and easily used without specialized training will prove particularly useful in locations and settings without high-end advanced capabilities (e.g., genomic tests) due to limited resources."
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
429056
Name
Sprenger Jillian R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A Novel Method of Stromal Analysis Based on Polarized Light Microscopy is Prognostic of Breast Cancer Progression and Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biophotonics; Biophysics; Breast Cancer; Collagen; Imaging; Microscopy; Polarized Light; Prognostic; Tumour Stroma
Abstract
"Breast cancer is one of the most commonly diagnosed cancers and is the leading cause of cancer death among women worldwide. It is a highly heterogenous disease with much variation among patients in terms of disease progression and aggressiveness. Despite this known heterogeneity, personalized therapy based on prognostic markers remains difficult to implement, often leading to over- or under-treatment. The morphologic features of the tumour-associated stroma have recently been shown to contain prognostic information. In response, our group has developed a simple and inexpensive method to evaluate stromal morphology based on polarized light microscopy. By exploiting the birefringent properties of collagen (a major component of the stroma) and its interaction with polarized light, it is possible to visualize the stroma to glean prognostic information. We have also developed a ""stromal architecture signature"" (SAS), a numerical score that quantifies the patterns of stromal morphology. This research will further develop this novel methodology and will examine how the SAS is prognostic of breast cancer progression and outcomes. It will also produce a clinical workflow to facilitate uptake of this method and use of its prognostic data as a step toward making personalized therapy more readily available. An approach that is inexpensive, reliable, and easily used without specialized training will prove particularly useful in locations and settings without high-end advanced capabilities (e.g., genomic tests) due to limited resources."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sprenger, Jillian R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~